Elizabeta Nemeth is an American physiologist who has made many contributions to the understanding of inflammatory disorders, thalassemias, and iron overload diseases.[1]

Biography

edit

Nemeth obtained her degree in molecular biology and physiology from the University of Belgrade and then earned a neuroscience degree from the University of Hawaii in 1998. She did postdoctoral research in the area of ovarian cancer and later worked at the Cedars-Sinai Medical Center in Los Angeles, California. In 2001, she became a member of the Department of Medicine at UCLA, where she worked on iron metabolism and the hormone hepcidin.[2][3] In 2007, the American College of Nutrition honored her with the Grace Goldsmith Award.[4] Currently she is a co-founder of Intrinsic LifeSciences,[4] and is an associate professor at the UCLA Center for Iron Disorders.[5] Her research has suggested treatments for anemia and iron overload.[6]

References

edit
  1. ^ "Elizabeta Nemeth Ph.D." Bloomberg BusinessWeek. Retrieved September 27, 2013.[dead link]
  2. ^ "Researchers Identify How A Hormone Regulates Iron". Science Daily. October 29, 2004. Retrieved September 27, 2013.
  3. ^ "Elizabeta Nemeth". BloodMed. Archived from the original on September 28, 2013. Retrieved September 26, 2013.
  4. ^ a b "Elizabeta Nemeth, Ph.D." Intrinsic LifeSciences. Archived from the original on October 21, 2011. Retrieved September 26, 2013.
  5. ^ "Elizabeta Nemeth, Ph.D." UCLA. Archived from the original on July 12, 2010. Retrieved September 26, 2013.
  6. ^ "Metabolic Insight To Illuminate Causes Of Iron Imbalance". Science Daily. August 7, 2008. Retrieved September 27, 2013.